Wall Street Experts
ver. ZuMIgo(08/25)
Ionis Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 803
EBIT TTM (mln): -293
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
34 |
37 |
53 |
80 |
50 |
43 |
40 |
25 |
70 |
107 |
122 |
108 |
99 |
102 |
147 |
214 |
284 |
347 |
508 |
600 |
1,123 |
729 |
810 |
587 |
788 |
705 |
Przychód Δ r/r |
0.0% |
9.9% |
43.0% |
50.5% |
-37.7% |
-14.7% |
-5.8% |
-38.9% |
183.8% |
54.0% |
13.4% |
-10.8% |
-8.7% |
3.0% |
44.3% |
45.4% |
32.5% |
22.2% |
46.5% |
18.1% |
87.3% |
-35.1% |
11.1% |
-27.5% |
34.2% |
-10.5% |
Marża brutto |
115.3% |
114.9% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
-55.3% |
-25.0% |
-12.9% |
-13.6% |
0.7% |
26.2% |
99.7% |
99.6% |
98.4% |
98.6% |
97.6% |
98.8% |
98.4% |
EBIT (mln) |
-43 |
-29 |
-46 |
-51 |
-79 |
-118 |
-57 |
-68 |
-39 |
-13 |
-28 |
-48 |
-71 |
-69 |
-52 |
-48 |
-76 |
-46 |
25 |
-61 |
366 |
-172 |
-30 |
-411 |
-354 |
-475 |
EBIT Δ r/r |
0.0% |
-32.7% |
59.0% |
10.2% |
55.4% |
49.2% |
-51.5% |
19.1% |
-42.8% |
-66.5% |
110.9% |
75.6% |
47.0% |
-3.1% |
-25.0% |
-7.6% |
58.7% |
-38.9% |
-153.0% |
-350.2% |
-696.4% |
-147.0% |
-82.6% |
1270.0% |
-13.9% |
34.3% |
EBIT (%) |
-127.1% |
-77.8% |
-86.5% |
-63.4% |
-158.0% |
-276.5% |
-142.5% |
-277.7% |
-55.9% |
-12.2% |
-22.6% |
-44.6% |
-71.8% |
-67.5% |
-35.1% |
-22.3% |
-26.7% |
-13.4% |
4.8% |
-10.2% |
32.6% |
-23.6% |
-3.7% |
-70.0% |
-44.9% |
-67.4% |
Koszty finansowe (mln) |
0 |
0 |
-15 |
-17 |
-19 |
-23 |
-20 |
-9 |
-8 |
-6 |
13 |
13 |
17 |
21 |
19 |
22 |
37 |
39 |
45 |
45 |
49 |
45 |
4 |
8 |
76 |
84 |
EBITDA (mln) |
-31 |
-6 |
-45 |
-49 |
-66 |
-39 |
-34 |
-64 |
-32 |
-5 |
-28 |
-38 |
-60 |
-52 |
-52 |
-28 |
-56 |
-46 |
21 |
-62 |
366 |
-172 |
-21 |
-561 |
-323 |
-475 |
EBITDA(%) |
-90.6% |
-15.0% |
-85.4% |
-61.0% |
-131.6% |
-91.0% |
-83.7% |
-261.8% |
-46.7% |
-4.9% |
-22.6% |
-35.1% |
-61.0% |
-50.9% |
-35.1% |
-13.0% |
-19.6% |
-13.4% |
4.1% |
-10.3% |
32.6% |
-23.6% |
-2.6% |
-95.6% |
-41.0% |
-67.4% |
Podatek (mln) |
16 |
24 |
9 |
7 |
18 |
57 |
22 |
-23 |
-28 |
-1 |
3 |
0 |
0 |
-9 |
-6 |
-15 |
0 |
3 |
-6 |
-291 |
44 |
317 |
-1 |
12 |
32 |
-6 |
Zysk Netto (mln) |
-59 |
-53 |
-74 |
-72 |
-95 |
-143 |
-72 |
-46 |
-11 |
-12 |
155 |
-61 |
-85 |
-65 |
-61 |
-39 |
-88 |
-87 |
-6 |
274 |
294 |
-487 |
-29 |
-270 |
-366 |
-454 |
Zysk netto Δ r/r |
0.0% |
-9.7% |
38.0% |
-2.2% |
31.5% |
50.0% |
-49.2% |
-36.6% |
-76.0% |
8.8% |
-1396.2% |
-139.5% |
38.4% |
-22.8% |
-7.4% |
-35.7% |
126.4% |
-2.0% |
-93.1% |
-4685.3% |
7.4% |
-265.6% |
-94.0% |
831.0% |
35.7% |
23.9% |
Zysk netto (%) |
-174.6% |
-143.6% |
-138.6% |
-90.1% |
-190.0% |
-334.3% |
-180.4% |
-187.1% |
-15.8% |
-11.2% |
127.5% |
-56.5% |
-85.6% |
-64.2% |
-41.2% |
-18.2% |
-31.1% |
-25.0% |
-1.2% |
45.6% |
26.2% |
-66.8% |
-3.6% |
-46.0% |
-46.5% |
-64.4% |
EPS |
-2.06 |
-1.44 |
-1.67 |
-1.33 |
-1.71 |
-2.52 |
-1.15 |
-0.62 |
-0.13 |
-0.13 |
1.58 |
-0.62 |
-0.85 |
-0.65 |
-0.55 |
-0.33 |
-0.74 |
-0.72 |
-0.0481 |
2.07 |
2.12 |
-3.49 |
-0.21 |
-1.9 |
-2.56 |
-3.04 |
EPS (rozwodnione) |
-2.06 |
-1.44 |
-1.67 |
-1.33 |
-1.71 |
-2.52 |
-1.15 |
-0.62 |
-0.13 |
-0.13 |
1.58 |
-0.62 |
-0.85 |
-0.65 |
-0.55 |
-0.33 |
-0.74 |
-0.72 |
-0.0473 |
2.04 |
2.08 |
-3.49 |
-0.21 |
-1.9 |
-2.56 |
-3.04 |
Ilośc akcji (mln) |
29 |
37 |
44 |
54 |
55 |
57 |
63 |
74 |
84 |
95 |
98 |
99 |
100 |
101 |
111 |
118 |
119 |
121 |
124 |
132 |
140 |
140 |
141 |
142 |
143 |
150 |
Ważona ilośc akcji (mln) |
29 |
37 |
44 |
54 |
55 |
57 |
63 |
74 |
84 |
95 |
98 |
99 |
100 |
101 |
111 |
118 |
120 |
121 |
126 |
134 |
143 |
140 |
141 |
142 |
143 |
150 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |